• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How to Diagnose and Manage Patients With Fluoropyrimidine-Induced Chest Pain: A Single Center Approach.

作者信息

Padegimas Allison, Carver Joseph R

机构信息

Department of Medicine, Division of Cardiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

JACC CardioOncol. 2020 Nov 17;2(4):650-654. doi: 10.1016/j.jaccao.2020.06.012. eCollection 2020 Nov.

DOI:10.1016/j.jaccao.2020.06.012
PMID:34396276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8352252/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb5/8352252/8c79e47f6a6d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb5/8352252/3cd29ef2542b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb5/8352252/97b787894921/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb5/8352252/8c79e47f6a6d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb5/8352252/3cd29ef2542b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb5/8352252/97b787894921/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb5/8352252/8c79e47f6a6d/gr2.jpg

相似文献

1
How to Diagnose and Manage Patients With Fluoropyrimidine-Induced Chest Pain: A Single Center Approach.如何诊断和处理氟尿嘧啶诱导的胸痛患者：单中心方法
JACC CardioOncol. 2020 Nov 17;2(4):650-654. doi: 10.1016/j.jaccao.2020.06.012. eCollection 2020 Nov.
2
Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine.在经历过输注 5-FU 或卡培他滨引起的冠状动脉痉挛的患者中，奥沙利铂联合推注 5-氟尿嘧啶（5-FU）是安全且耐受良好的。
Clin Colorectal Cancer. 2019 Mar;18(1):52-57. doi: 10.1016/j.clcc.2018.09.006. Epub 2018 Oct 10.
3
5-Fluorouracil Rechallenge After Cardiotoxicity.心脏毒性后再次使用5-氟尿嘧啶
Am J Case Rep. 2020 Aug 29;21:e924446. doi: 10.12659/AJCR.924446.
4
Successful 5-fluorouracil (5-FU) infusion re-challenge in a metastatic colorectal cancer patient with coronary artery disease who experienced symptoms consistent with coronary vasospasm during first 5-FU infusion.一名患有冠状动脉疾病的转移性结直肠癌患者在首次输注5-氟尿嘧啶（5-FU）期间出现与冠状动脉痉挛相符的症状，5-FU输注再次挑战成功。
J Gastrointest Oncol. 2019 Oct;10(5):1010-1014. doi: 10.21037/jgo.2019.07.04.
5
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.奥沙利铂、氟尿嘧啶和亚叶酸钙与氟尿嘧啶和亚叶酸钙作为术前放化疗后局部进展期直肠癌的辅助化疗（ADORE）：一项开放标签、多中心、2 期、随机对照临床试验。
Lancet Oncol. 2014 Oct;15(11):1245-53. doi: 10.1016/S1470-2045(14)70377-8. Epub 2014 Sep 4.
6
A Case of 5-Fluorouracil-Induced Cardiac Arrest.一例5-氟尿嘧啶诱发的心脏骤停病例。
J Emerg Med. 2016 Jan;50(1):e1-6. doi: 10.1016/j.jemermed.2015.09.001. Epub 2015 Oct 9.
7
Bevacizumab in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in patients with metastatic colorectal cancer who were previously treated with oxaliplatin-containing regimens: a multicenter observational cohort study (TCTG 2nd-BV study).贝伐珠单抗联合伊立替康、5-氟尿嘧啶和亚叶酸（FOLFIRI）治疗既往含奥沙利铂方案治疗的转移性结直肠癌患者：一项多中心观察性队列研究（TCTG 2 期-BV 研究）。
Med Oncol. 2012 Dec;29(4):2842-8. doi: 10.1007/s12032-011-0151-2. Epub 2011 Dec 31.
8
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status.对于体能状态受损的75岁及以上晚期食管胃癌患者，采用FOLFOX - 4方案治疗，随后给予亚叶酸钙/推注和持续输注5 - 氟尿嘧啶作为维持化疗。
J Geriatr Oncol. 2015 Sep;6(5):380-6. doi: 10.1016/j.jgo.2015.06.002. Epub 2015 Jul 27.
9
Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study.酪氨酸激酶抑制剂、免疫检查点抑制剂联合肝动脉灌注奥沙利铂和雷替曲塞与奥沙利铂、5-氟尿嘧啶和亚叶酸钙治疗中晚期肝细胞癌的对比：一项回顾性研究
Int Immunopharmacol. 2023 Dec;125(Pt A):111019. doi: 10.1016/j.intimp.2023.111019. Epub 2023 Oct 24.
10
Is XELOX equivalent to FOLFOX or other continuous-infusion 5-fluorouracil chemotherapy in metastatic colorectal cancer?
Clin Colorectal Cancer. 2008 May;7(3):206-11. doi: 10.3816/CCC.2008.n.029.

引用本文的文献

1
Fluoropyrimidines: A Cardiotoxicity Case for Caution.氟嘧啶：一个需谨慎对待心脏毒性的案例。
JACC Case Rep. 2025 Aug 27;30(25):104738. doi: 10.1016/j.jaccas.2025.104738.
2
Fluoropyrimidine Therapy in Gastrointestinal Cancer: Balancing Survival Benefits and Cardiotoxicity Risks.胃肠道癌中的氟嘧啶治疗：平衡生存获益与心脏毒性风险
JACC CardioOncol. 2025 Jun;7(4):357-359. doi: 10.1016/j.jaccao.2025.02.006. Epub 2025 Apr 8.
3
Cardiovascular Considerations During Cancer Therapy: Gaps in Evidence and Expert Panel Recommendations.

本文引用的文献

1
5-FU induced cardiotoxicity: case series and review of the literature.5-氟尿嘧啶诱导的心脏毒性：病例系列及文献综述
Cardiooncology. 2019 Sep 6;5:13. doi: 10.1186/s40959-019-0048-3. eCollection 2019.
2
Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine.在经历过输注 5-FU 或卡培他滨引起的冠状动脉痉挛的患者中，奥沙利铂联合推注 5-氟尿嘧啶（5-FU）是安全且耐受良好的。
Clin Colorectal Cancer. 2019 Mar;18(1):52-57. doi: 10.1016/j.clcc.2018.09.006. Epub 2018 Oct 10.
3
5-fluorouracil and cardiotoxicity: a review.
癌症治疗期间的心血管问题：证据差距与专家小组建议
JACC CardioOncol. 2024 Nov 5;6(6):815-834. doi: 10.1016/j.jaccao.2024.06.005. eCollection 2024 Dec.
4
Investigating the effect of cancer medication in the development of Takotsubo cardiomyopathy.研究癌症药物在应激性心肌病发展中的作用。
Am J Cardiovasc Dis. 2024 Aug 25;14(4):196-207. doi: 10.62347/STFL9135. eCollection 2024.
5
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment.抗癌药物的心脏毒性：分子机制、临床管理和创新治疗。
Drug Des Devel Ther. 2024 Sep 12;18:4089-4116. doi: 10.2147/DDDT.S469331. eCollection 2024.
6
Chemotherapy-related cardiotoxicity and its symptoms in patients with breast cancer: a scoping review.化疗相关性心脏毒性及其在乳腺癌患者中的症状：系统评价。
Syst Rev. 2024 Jun 27;13(1):167. doi: 10.1186/s13643-024-02588-z.
7
Vascular disease in cancer: Current and emerging concepts.癌症中的血管疾病：当前与新兴概念
Am Heart J Plus. 2022 May 21;17:100143. doi: 10.1016/j.ahjo.2022.100143. eCollection 2022 May.
8
Capecitabine-induced-coronary-vasospasm leading to polymorphic ventricular tachycardia and cardiac arrest.卡培他滨诱发冠状动脉痉挛，导致多形性室性心动过速和心脏骤停。
Cardiooncology. 2024 Feb 27;10(1):11. doi: 10.1186/s40959-024-00214-4.
9
Identification Drug Targets for Oxaliplatin-Induced Cardiotoxicity without Affecting Cancer Treatment through Inter Variability Cross-Correlation Analysis (IVCCA).通过互变异构体交叉相关性分析（IVCCA）鉴定奥沙利铂诱导心脏毒性的药物靶点，同时不影响癌症治疗。
bioRxiv. 2024 Feb 12:2024.02.11.579390. doi: 10.1101/2024.02.11.579390.
10
Management of Fluoropyrimidine-Induced Cardiac Adverse Outcomes Following Cancer Treatment.癌症治疗后氟嘧啶类药物引起的心脏不良结局的管理。
Cardiovasc Toxicol. 2024 Feb;24(2):184-198. doi: 10.1007/s12012-024-09834-9. Epub 2024 Feb 7.
5-氟尿嘧啶与心脏毒性：综述
Ther Adv Med Oncol. 2018 Jun 18;10:1758835918780140. doi: 10.1177/1758835918780140. eCollection 2018.
4
Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm.氟嘧啶诱导的心脏毒性：挑战当前范式。
J Gastrointest Oncol. 2017 Dec;8(6):970-979. doi: 10.21037/jgo.2017.09.07.
5
Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.卡培他滨所致症状性心脏毒性的发生率及危险因素：对452例连续性转移性乳腺癌患者的回顾性研究
BMJ Open. 2016 Oct 19;6(10):e012798. doi: 10.1136/bmjopen-2016-012798.
6
Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes.5-氟尿嘧啶对内皮细胞和心肌细胞的形态、细胞周期、增殖、凋亡、自噬及活性氧生成的影响
PLoS One. 2015 Feb 11;10(2):e0115686. doi: 10.1371/journal.pone.0115686. eCollection 2015.
7
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity.5-氟尿嘧啶致心脏毒性的病理生理学系统评价。
BMC Pharmacol Toxicol. 2014 Sep 4;15:47. doi: 10.1186/2050-6511-15-47.
8
Fluorouracil induces myocardial ischemia with increases of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle.氟尿嘧啶引起心肌缺血，导致血浆脑利钠肽和乳酸增加，但左心室功能无异常。
J Clin Oncol. 2010 Dec 20;28(36):5280-6. doi: 10.1200/JCO.2009.27.3953. Epub 2010 Nov 15.
9
FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer.用于可切除的II期和III期结肠癌辅助治疗的FOLFOX和FLOX方案。
Cancer Invest. 2008 Nov;26(9):956-63. doi: 10.1080/07357900802132550.
10
Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil.
Acta Oncol. 1990;29(8):1001-3. doi: 10.3109/02841869009091790.